JP2023535035A5 - - Google Patents
Info
- Publication number
- JP2023535035A5 JP2023535035A5 JP2023504356A JP2023504356A JP2023535035A5 JP 2023535035 A5 JP2023535035 A5 JP 2023535035A5 JP 2023504356 A JP2023504356 A JP 2023504356A JP 2023504356 A JP2023504356 A JP 2023504356A JP 2023535035 A5 JP2023535035 A5 JP 2023535035A5
- Authority
- JP
- Japan
- Prior art keywords
- body weight
- days
- approximately
- pharmaceutical composition
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010713637.0 | 2020-07-22 | ||
| CN202010713637 | 2020-07-22 | ||
| PCT/CN2021/107575 WO2022017412A1 (zh) | 2020-07-22 | 2021-07-21 | 治疗造血干细胞移植后的移植物抗宿主病的方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535035A JP2023535035A (ja) | 2023-08-15 |
| JP2023535035A5 true JP2023535035A5 (enExample) | 2024-07-29 |
| JP7803924B2 JP7803924B2 (ja) | 2026-01-21 |
Family
ID=79728482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504356A Active JP7803924B2 (ja) | 2020-07-22 | 2021-07-21 | 造血幹細胞移植によって引き起こされる移植片対宿主病を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230285393A1 (enExample) |
| EP (1) | EP4186508A4 (enExample) |
| JP (1) | JP7803924B2 (enExample) |
| KR (1) | KR20230043891A (enExample) |
| CN (2) | CN116322670A (enExample) |
| AU (1) | AU2021313124A1 (enExample) |
| BR (1) | BR112023001049A2 (enExample) |
| CA (1) | CA3186564A1 (enExample) |
| IL (1) | IL299985A (enExample) |
| TW (2) | TW202216691A (enExample) |
| WO (1) | WO2022017412A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4393917A4 (en) * | 2021-09-18 | 2025-09-10 | Beijing Tide Pharmaceutical Co Ltd | SOLID FORM OF A RHO-ASSOCIATED PROTEIN KINASE INHIBITOR OR SOLVATE THEREOF, METHOD OF PREPARATION AND USE THEREOF |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011009568A (es) * | 2009-03-09 | 2011-12-06 | Surface Logix Inc | Inhibidores de la rho cinasa. |
| PL2903618T3 (pl) * | 2012-10-05 | 2022-09-19 | Kadmon Corporation, Llc | Inhibitory kinazy rho |
| EP3504204A4 (en) * | 2016-08-26 | 2020-05-27 | Lycera Corporation | INDAZOLYL-L, 2,4-THIADIAZOLAMINE AND RELATED COMPOUNDS FOR INHIBITING RHO-ASSOCIATED PROTEIN KINASES AND FOR TREATING DISEASES |
| JP7311228B2 (ja) | 2017-06-30 | 2023-07-19 | ベイジン タイド ファーマシューティカル カンパニー リミテッド | Ｒｈｏ－関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用 |
| CN110582491B (zh) * | 2017-06-30 | 2023-09-29 | 北京泰德制药股份有限公司 | Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途 |
| KR102563325B1 (ko) | 2017-06-30 | 2023-08-03 | 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 | Ｒｈｏ-관련 단백질 키나아제 억제제, Ｒｈｏ-관련 단백질 키나아제 억제제를 함유하는 약학 조성물, 제조 방법 및 약학 조성물의 용도 |
| TWI881481B (zh) * | 2017-08-15 | 2025-04-21 | 美商歐米諾斯公司 | 用於治療和／或預防與造血幹細胞移植有關的移植物抗宿主病和／或瀰漫性肺泡出血和／或靜脈閉塞性病的方法 |
-
2021
- 2021-07-21 CN CN202180059344.8A patent/CN116322670A/zh active Pending
- 2021-07-21 WO PCT/CN2021/107575 patent/WO2022017412A1/zh not_active Ceased
- 2021-07-21 US US18/017,198 patent/US20230285393A1/en active Pending
- 2021-07-21 TW TW110126814A patent/TW202216691A/zh unknown
- 2021-07-21 EP EP21845732.3A patent/EP4186508A4/en active Pending
- 2021-07-21 CA CA3186564A patent/CA3186564A1/en active Pending
- 2021-07-21 BR BR112023001049A patent/BR112023001049A2/pt unknown
- 2021-07-21 TW TW112113471A patent/TWI868660B/zh active
- 2021-07-21 KR KR1020237005450A patent/KR20230043891A/ko active Pending
- 2021-07-21 JP JP2023504356A patent/JP7803924B2/ja active Active
- 2021-07-21 AU AU2021313124A patent/AU2021313124A1/en active Pending
- 2021-07-21 CN CN202610271426.3A patent/CN121846099A/zh active Pending
- 2021-07-21 IL IL299985A patent/IL299985A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022539329A5 (enExample) | ||
| JP2022522486A5 (enExample) | ||
| JP2020125355A (ja) | 併用療法 | |
| CN115190815A (zh) | 芳基环己基胺衍生物及其在精神障碍的治疗中的用途 | |
| JP6745726B2 (ja) | 中枢神経系障害の処置における２，４−チアゾリジンジオン誘導体 | |
| JP2022539329A (ja) | 特発性肺線維症を治療する方法 | |
| JP6218940B2 (ja) | キニン系化合物、その光学異性体及びその製造方法と医薬用途 | |
| JP2013519653A5 (enExample) | ||
| TW201247613A (en) | Ester derivatives of bimatoprost compositions and methods | |
| WO2021060453A1 (ja) | 架橋型光学活性２級アミン誘導体 | |
| JP7508620B2 (ja) | ジヒドロクロメン誘導体 | |
| JP2017522304A5 (enExample) | ||
| JP2023535035A5 (enExample) | ||
| TW202304914A (zh) | 經取代之四環羧酸、其類似物及使用其之方法 | |
| JP2022531570A5 (enExample) | ||
| JP2022530890A5 (enExample) | ||
| JPH06211660A (ja) | 神経成長因子産生促進剤 | |
| RU2013149416A (ru) | Производные камптотецина, обладающие противоопухолевой активностью | |
| CN117616019A (zh) | 作为pcsk9抑制剂的新化合物 | |
| EP1674100A1 (en) | Angiogenesis inhibitor | |
| US20140309275A1 (en) | Sphingosine Analogs, Compositions, and Methods Related Thereto | |
| JP2006347942A (ja) | βアミロイド生成抑制剤 | |
| JP2005298340A (ja) | 疼痛治療薬 | |
| TW202425969A (zh) | 吲唑吡啶酮化合物及其用途 | |
| JP2020507608A5 (enExample) |